Acceptance of baits for delivery of oral rabies vaccine to raccoons.

During 1993-96 the Ontario Ministry of Natural Resources (Canada) implemented a research project to evaluate the efficacy of three candidate baits to deliver oral rabies vaccine to wild raccoons (Procyon lotor). Extensive field testing revealed that raccoon acceptance of Sugar-Vanilla baits (SV) at densities of 200/km2 and 400/km2, hand-placed in urban habitats of Scarborough (Ontario) during 1993, was 74% and 82%, respectively. Raccoon density in those areas averaged 11/km2. Aerial placement of SV baits in rural habitats in Barrie (Ontario) during 1993 and 1994, yielded raccoon acceptance levels of 58% with a density of 100 baits/km2, 59% at 75 baits/km2, and 47% at 50 baits/km2. Raccoon acceptance of SV baits was significantly lower in areas baited at the density of 50/km2. Acceptance of Cheese baits (CH) at a density of 75 baits/km2 was 52%. During 1996 trials in Barrie, modified SV baits with blister packs protruding through the matrix yielded raccoon acceptance values of 51% at a bait density of 54/km2, whereas acceptance of regular SV baits was 39% at a density of 51 baits/km2. Pooling of bait acceptance data for all years revealed that bait acceptance was highest for adult male raccoons. Raccoon density in rural habitats (Barrie, Ontario) where the studies took place, averaged 11-13/km2. Puncture and impact testing of blister packs in baits suggested that they would adequately serve as a vehicle to contain oral rabies vaccine for delivery to raccoons via baits.     

Acceptance of simulated oral rabies vaccine baits by urban raccoons

In summer 1986, a study was conducted to evaluate raccoon (Procyon lotor) acceptance of oral baits that could be used for rabies vaccination. One thousand wax-coated sponge bait cubes were filled with 5 mg of a seromarker (iophenoxic acid), placed in polyethylene bags, and hand-distributed in an 80 ha area within an urban National Park in Washington, D. C. (USA). After 3 wk, target and nontarget animals were trapped and blood samples collected to evaluate bait uptake. Thirty-three of 52 (63%) raccoons had elevated blood iodine levels indicating they had eaten at least one bait, 13 (25%) were negative, and six (12%) had marginal values. These results indicate that sponge baits hand-placed at a density of 12.4/ha can reach a significant proportion of an urban raccoon population. Implications for oral rabies vaccination of raccoons are discussed.     

A modified bait for oral delivery of biological agents to raccoons and feral swine

A field study was conducted on Ossabaw Island (Georgia, USA) in March 1994 to evaluate four different types of bait for delivering orally effective biological agents to raccoons (Procyon lotor) and feral swine (Sus scrofa). A deep-fried corndog batter bait, which was previously shown to be ingested by both captive and free-ranging raccoons, and a polymer fishmeal bait which had been shown effective for both raccoons and feral swine were compared with a grain-based dog food meal polymer bait topically coated with corn oil and cornmeal or with fish oil and fishmeal. Tracking stations were used to determine the number of each bait type visited and removed by animals visiting stations. We found no significant differences in the numbers of different baits removed by either species. These data support the results of earlier studies which also indicated that an inexpensive grain-based matrix bait surface-coated with attractive flavors can be used to deliver oral biologics to problem species.     

Prerequisites for oral immunization of free-ranging raccoons (Procyon lotor) with a recombinant rabies virus vaccine: study site ecology and bait system development.

A model baiting system suitable for the delivery of an oral rabies vaccine to free-ranging raccoons (Procyon lotor) was developed and tested on barrier islands in South Carolina (USA). Features of barrier island physiography and ecology were studied relative to selective bait deployment and site biosecurity. Capture-mark-recapture data were obtained from 228 raccoons. Raccoon density estimates, using a modified census assessment technique, were one raccoon per 1.8 to 2.7 ha. Mean (+/- SE) and range home area estimates of radio-collared raccoons were 84 (+/- 15.6) ha (27 to 176 ha) by a minimum convex polygon method and 138 (+/- 22.8) ha (43 to 241 ha), by a harmonic mean transformation method. Habitat utilization determinations of radio-collared raccoons were conducted to identify study areas to potentially maximize selectivity of bait towards raccoons and to reduce the absolute number of baits deployed. Island raccoons showed a habitat preference for maritime forest, maritime shrub and marsh areas. Additionally, there was no evidence of inter-island or mainland exchange of ear-tagged or radio-collared raccoons. A disease and mortality survey was conducted to identify baseline pathology and incidental lesions in the target raccoon population, prior to actual vaccination initiation. Thirty-eight percent of 30 clinically suspect raccoons sampled had intracytoplasmic eosinophilic inclusions diagnostic of canine distemper; no other lesions suggestive of viral etiologies were found. Serological surveys for raccoon poxvirus and rabies virus antibodies were negative. Antibody titers to canine adenovirus 1 and 2 indicated a moderate level of exposure (approximately 10 to 16%) in the raccoon population. Overall, 93 to 100% of placebo baits were consistently disturbed by 7 days post-bait deployment, and bait acceptance rates by raccoons ranged from 49 to 85%, by using a modular systems approach to select the optimum combination of bait attractant, biomarker, matrix, density, and distribution. These results suggest that a large proportion (up to 85%) of a free-ranging island raccoon population can be selectively and safely targeted, marked and monitored utilizing a proposed oral bait delivery system for recombinant or other rabies vaccines.     

Bait delivery for oral rabies vaccine to gray foxes

Rabies is a widespread zoonotic disease that has reached epizootic proportions in gray foxes (Urocyon cinereoargenteus) in central Texas. Because each species of carnivore has different food preferences and foraging strategies, it is essential that the efficacy of a bait delivery program be examined for gray foxes prior to an oral vaccination program being attempted. Field trials were conducted to determine bait preferences of free-ranging gray foxes to selected baits and odor attractants. Baits consisted of polymer cubes made of either dog food meal or fish meal, and a wax-lard cake that was enhanced with marshmallow flavoring. Attractants added to baits exuded sulfurous, fatty, cheesy, or sweet odors and flavors. During 3,589 operable bait station nights, gray fox visitation and bait uptake rates were 9.2% and 8.3%, respectively. Gray foxes exhibited no preference in bait uptake rates between bait and odor attractant combinations. Gray foxes exhibited no difference in cumulative bait uptake rates between onroad and offroad sites; however, the uptake rate by raccoons was significantly greater for baits placed on roads than for baits randomly placed. Raccoons were the major non-target species competing for baits, being attributed with 73% of the total uptake. Visitation and bait uptake rates by raccoons significantly increased after a 7-day lethal removal of raccoons (n = 37) from the study area. Random distribution of baits is recommended; it reduced bait uptake by non-target species without adversely affecting uptake by gray foxes.     

Oral efficacy of an attenuated rabies virus vaccine in skunks and raccoons

Raccoons and skunks are major rabies reservoirs in North America. Oral vaccination is one method to consider for disease control in these carnivores. Under field conditions in the USA, only one oral rabies vaccine has been used. It is efficacious in wildlife such as raccoons (Procyon lotor), coyotes (Canis latrans), and foxes (Vulpes vulpes) but not in skunks (Mephitis mephitis). The objectives of this study were to evaluate an attenuated SAG-2 rabies virus vaccine for safety, immunogenicity, and efficacy by the oral route in skunks and raccoons. Two of five skunks and three of five raccoons developed virus neutralizing antibodies (VNA) by day 14 following oral administration of SAG-2 vaccine. All animals remained healthy. Upon challenge, naive controls succumbed to rabies. Among vaccinated animals, four of five skunks and all five raccoons had VNA on day 7 post-challenge and all survived. Given these results, SAG-2 is a promising candidate vaccine that may satisfy both safety and efficacy concerns for oral rabies immunization of major North American rabies reservoirs.     

Development of a bait and baiting system for delivery of oral rabies vaccine to free-ranging African wild dogs (Lycaon pictus)

The objective of the study was to develop a bait and baiting system capable of delivering one effective dose of oral rabies vaccine to each member of a free-ranging African wild dog (Lycaon pictus) pack. Trials were conducted between June and October 2000. The results of cafeteria-style bait preference trials testing seven candidate baits in captive wild dogs revealed a significant preference for chicken heads (June trials: P = 0.023, September trials: P = 0.021). Trials using a topical biomarker (rhodamine B) showed that chicken head baits were sufficiently chewed on most occasions to rupture the vaccine container. Free-ranging wild dogs and young pups ingested chicken head baits. Significant dominance of bait intake by a single individual was seen in four of six study packs and in the three packs in which an alpha pair could be distinguished, the dominant feeder was an alpha animal. Pattern of bait distribution and degree of satiation had no effect on pack coverage (proportion of pack ingesting at least one bait). Pack coverage was significantly related to trial number (r = 0.71, P < 0.001), with pack coverage increasing with increased exposure of the pack to the baits. During 46 hr of diurnal observations of free-ranging wild dogs only two baits were lost to non-target species. A baiting system for the oral vaccination of captive and free-ranging wild dogs is proposed.     

Trap-vaccinate-release and oral vaccination for rabies control in urban skunks, raccoons and foxes.

Two rabies control tactics, trap-vaccinate-release (T-V-R) and oral vaccination were used for the control of rabies in skunks (Mephitis mephitis), raccoons (Procyon lotor), and foxes (Vulpes vulpes) in metropolitan Toronto, Canada. Using T-V-R, a mean of 45% to 72% (95% confidence limits of 40% to 81%) of the skunks and a mean of 17% to 68% (95% confidence limits of 14% to 76%) of the raccoons in a 60 km2 area of Toronto were vaccinated against rabies between 1987 and 1991. The area has been free of skunk rabies from May 1989 to April 1992. Forty-five rabies cases were diagnosed during 1980 to 1986. In contrast, only three skunk cases have been reported since the vaccination program began in July 1987. The T-V-R area also remained rabies free during an epizootic of skunk rabies in metropolitan Toronto during 1991. Following distribution of rabies vaccine-baits throughout the ravines of metropolitan Toronto, June 1989 to December 1991, 46% to 80% of the Toronto fox population was immunized during 1989, 1990 and 1991. Only one case of fox rabies was reported in metropolitan Toronto since vaccination began, compared to 80 cases reported between 1982 and 1988. The area has been free of reported fox rabies from October 1990 to April 1992.     

Formulation and evaluation of baits for oral rabies vaccination of raccoons (Procyon lotor)

Captive raccoons were offered a variety of vaccine containers and bait components in a series of three-choice tests. Paraffin wax ampules were the most readily accepted vaccine container. Preferred bait components included corn and shellfish oils, deep fried corn meal batter, and egg, apple and buttermilk flavorings. These results, together with factors including ease of bait formulation, cost, and suitability for field use, were used to develop an experimental delivery system for an oral rabies vaccine. The developed system was composed of a polyurethane sleeve (1.5 x 5.5 cm) dipped in a commercial food batter mix together with corn meal, milk and egg. The sleeve was deep fried in corn oil and a 2.0 ml ampule containing a recombinant rabies vaccine was then inserted into the sleeve bait. These baits were presented to 10 captive raccoons. Nine of the 10 animals developed high levels of rabies virus neutralizing antibodies. Field tests are needed to determine if the delivery system developed also is effective for wild raccoons.     

A study of techniques for the distribution of oral rabies vaccine to wild raccoon populations

This study evaluates a technique for delivering an oral rabies vaccine to wild raccoon (Procyon lotor) populations. Various baits and attractants were first tested on caged raccoons and baiting trials were then conducted in two distinct physiographic regions of Virginia (USA), the coastal plain and the Piedmont plateau. Raccoon population density studies preceded the field trials. Each polyurethane sponge bait distributed contained approximately 200 mg tetracycline as a tissue biomarker, and was presented in an outer bag with a fish-based attractant. Baits were frozen until used and distributed from an aeroplane throughout two 4-km2 sites in each region. One site received 450 baits/km2 and the other 120 baits/km2. Postbaiting evaluation included the direct observation of baits in the field and the examination of teeth and bone from trapped and hunted animals for evidence of the biomarker. Between 30% and 73% of the captured animals showed evidence of bait consumption. The proportion of animals with evidence of bait uptake changed when areas adjacent to the actual baiting site were included. The percentage of animals taking baits was not related to the density of baits that were distributed.     

Oral rabies vaccine (ORV) bait uptake by captive striped skunks

Aerial delivery of oral rabies vaccine (ORV) baits has proven effective in large-scale efforts to immunize wildlife against rabies, and in North America this strategy currently is being used to immunize foxes (Urocyon cinereoargenteus and Vulpes vulpes), raccoons (Procyon lotor), and coyotes (Canis latrans). Skunks are also a major reservoir and vector of rabies, but at present oral vaccines for use in skunks are not licensed. Furthermore, given differences in morphology (smaller jaws) and behavior (food handling and consumption), it is unknown if baits currently used in ORV campaigns would be effective for skunks. Because oral vaccine delivery is contingent upon puncture of the vaccine container (VC), baits need to be sufficiently attractive to elicit selection and consumption. Manipulation of the bait to facilitate vaccine ingestion by the target species is a critical element for an effective ORV bait. The objectives of this study were to assess manipulation and consumption of current ORV baits by striped skunks (Mephitis mephitis). We conducted four independent trials with penned animals and various baits to assess bait selection frequency, VC puncture frequency, and consumption. Video recorded trials were used to assess attractiveness of baits and consumption behavior of skunks. Bait characteristics, such as texture, size, and flavor influenced selection and consumption. Fish and chicken flavors were preferred and vaccine containers within selected baits were likely to be punctured. Vaccine ingestion seemed more likely if VCs were directly coated with the bait matrix. To make baits attractive to skunks and to ensure puncture of the VC, modifications to current baits should consider a smaller size, a meat-flavored matrix, a slightly pressurized VC, and a direct coating of matrix on the VC.     

Vaccination of free-ranging Pennsylvania raccoons (Procyon lotor) with inactivated rabies vaccine

Thirty-nine free-ranging raccoons (Procyon lotor) in an endemic rabies area of Pennsylvania (USA) were vaccinated with a single intramuscular inoculation of commercial inactivated rabies virus vaccine, 17 June to 23 August 1987. Paired serum samples, pre- and postvaccination, were obtained from eight raccoons and were analyzed in vitro for rabies virus neutralizing antibody using a modified rapid fluorescent focus inhibition test. Seven of eight (88%) recaptured raccoons demonstrated seroconversion within 15 to 26 days of vaccination. At 1 yr postvaccination, three vaccinated raccoons were recaptured and challenged in captivity with street rabies virus, resulting in the death of two of three vaccinates and five of five unvaccinated control raccoons.     

Oral rabies vaccine contact by raccoons and nontarget species in a field trial in Florida

Rabies is enzootic in raccoons (Procyon lotor) in the eastern United States. Oral vaccination of free-ranging raccoons against rabies has the potential to control the disease in a principal reservoir and reduce the risk of rabies exposure among domestic animals and humans. Free-ranging animal contact with baits containing a vaccinia virus recombinant vaccine expressing the rabies glycoprotein gene (V-RG) was monitored in Pinellas County (Florida, USA) from February through May 1997. Bait contact was assessed with 423 tracking plate nights; conducted in four land use zones: single residential, multiple residential, industrial-commercial, and undeveloped. The undeveloped land use zone was further described by six vegetation communities: mangrove swamp, red maple swamp, beach dune, pine forest, mixed oak hammock, and cabbage palm hammock. Seven animal taxa contacted the baited tracking plates across the four land use zones: raccoons, opossums (Didelphis virginiana), cats (Felis catus), dogs (Canis familiaris), rabbits (Sylvilagus sp.), unidentified rodents, and birds. A total of 252/413 (61%) of the baits was contacted by animals; 95 (38%) of these were specifically by the raccoon, the target species. Overall bait contact by all animals was significantly different among the four land use zones, being highest in the undeveloped zone (82%) and lowest in the industrial-commercial zone (34%). Bait contact by raccoons also was significantly different among the undeveloped and pooled urban zones. Among the six vegetation communities, bait contact by all animals was significantly different ranging from 95% in the mangrove to 50% in the cabbage palm hammock. Among the four vegetation communities tested, bait contact by raccoons also was significantly different.     

Serological responses of coyotes to two commercial rabies vaccines.

Between August 1993 and September 1994 we documented serological responses of coyotes (Canis latrans) vaccinated with two commercial rabies vaccines licensed for use in domestic dogs. Serologic responses were documented by testing for rabies virus neutralizing antibodies with the rapid fluorescent focus inhibition test (RFFIT) at 30, 90, 180, 270, and 365 days post-vaccination. All coyotes vaccinated with Imrab 3 (Rhone-Merieux, Inc.), and 75% of those vaccinated with Dura-Rab 3 (Immunovet, Inc.) seroconverted, as evidenced by the presence of antirabies antibody titers > or = 1:5 in one or more of the five post-vaccination samples. The percent of coyotes showing a titer > or = 1:5 was generally greater and titer levels appeared higher and more persistent among animals vaccinated with Imrab 3 than Dura-Rab 3. Presence of titers via RFFIT tests demonstrates the antibodies produced in coyotes by these rabies vaccines functionally bind and neutralize rabies virus in vitro, but these results do not constitute a demonstration of protection required for licensure for use in coyotes.     

Interference competition between coyotes and raccoons: a test of the mesopredator release hypothesis

Some predator species appear to conform to the mesopredatorrelease hypothesis (MRH), in which larger predators help limitpopulations of smaller predators. This hypothesis has been usedto explain the possible relationship between coyotes, mesopredators,and resultant cascades involving nonpredators. However, relationshipsbetween coyotes and noncanid mesopredators are poorly understood,and predictions from the MRH have rarely been rigorously tested.We monitored sympatric raccoon and coyote populations to assess2 predictions derived from the MRH: coyote predation is an importantcause of mortality in raccoon populations or raccoons avoidareas used by coyotes. Between March 2000 and September 2001,we recorded 3553 locations for 27 radio-collared raccoons and1393 locations for 13 coyotes captured on the Max McGraw WildlifeFoundation in Illinois, USA. No raccoon mortality from coyotepredation was observed during the study, and raccoon survivalwas >0.7 each season. All raccoon 95% home ranges exhibitedoverlap with 95% coyote home ranges in each season. The meanproportion of raccoon locations within 95% coyote home rangesdid not vary by sex but did vary by season. Raccoon overlapof coyote core areas varied considerably among individuals withinseasons, ranging from 0% to 83%. However, 45% of raccoons had<10% overlap with coyote core areas, whereas only 14% ofraccoons exhibited >50% overlap. Mean overlap with core areasdid not vary by season or sex. For those raccoons with homeranges overlapping coyote core areas, mean proportion of observedraccoon locations within coyote core areas was generally greaterthan the mean proportion of random locations. Scent-stationexperiments failed to document raccoon avoidance of specificsites that had been marked with coyote urine. We did not findsupport for a mortality prediction or avoidance prediction tosupport MRH with regard to raccoons and coyotes. These resultssuggest that relationships among mammalian predators may notbe simply dictated by body size, particularly for species outsidethe Canidae.     

A new rabies vaccine in public health practice in the USSR

A new antirabies vaccine prepared on the basis of virus grown in the ovine brain, purified from 85-90% of brain-tissue ballast substances and inactivated with beta-propilactone has been developed at the Moscow Research Institute of Viral preparations (USSR Acad. Med. Sci.). The preparation produces no neuro-allergenic effect in tests on guinea pigs. When injected to humans, the vaccine shows much lower reactogenicity than Fermi vaccine. High antigenic and immunogenic activity of the new vaccine has made it possible to work out a less intensive immunization schedule in comparison with that used for immunization with Fermi vaccine and nonconcentrated tissue-culture vaccine, viz. doses of 3 ml for 12 days or doses of 3 ml for 20 days with two booster immunizations. The preparation has been introduced into medical practice.     

Use of recombinant vaccinia-rabies glycoprotein virus for oral vaccination of wildlife against rabies: innocuity to several non-target bait consuming species

The pathogenicity of a vaccinia recombinant virus expressing the rabies glycoprotein (VVTGgRAB) was tested in several wild animal species which could compete with the natural rabies host, the red fox (Vulpes vulpes) in consuming vaccine baits in Europe. The following species were included in this study: wild boar (Sus scrofa), Eurasian badger (Meles meles), wood mouse (Apodemus sylvaticus), yellow-necked mouse (Apodemus flavicollis), bank vole (Clethrionomys glareolus), common vole (Microtus arvalis), field vole (Microtus agrestis), water vole (Arvicola terrestris), common buzzard (Buteo buteo), kestrel (Falco tinnunculus), carrion crow (Corvus corone), magpie (Pica pica) and jay (Garrulus glandarius). During the observation period, the 107 animals given the VVTGgRAB vaccine orally did not show any clinical signs. Daily monitoring for 28 days and postmortem examination did not result in the detection of pox lesions in the oral mucosa or the skin in mammals or the unfeathered portions of birds. VVTGgRAB seems to multiply in the mammalian species tested, since rabies seroconversion was observed in all of them. Birds failed to develop demonstrable rabies virus-neutralizing antibody. A seroconversion against vaccinia virus was observed in two of four wild boars. Serological results obtained in badgers and wild boars also demonstrates the absence of direct or indirect horizontal transmission of the recombinant virus. The potential of the recombinant virus for the immunization of badgers against rabies also was investigated. Only 50% of the badgers orally administered with 1 x 10(8.3) TCID50 of this vaccine were protected against rabies.